Wakuda K, Yamaguchi H, Kenmotsu H, Fukuda M, et al. A phase II study of Osimertinib for patients with radiotherapy-naive CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L). BMC Cancer 2020;20:370.
PMID: 32357848